These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16374383)

  • 1. The effects of granulocyte colony-stimulating factor in preclinical models of infection and acute inflammation.
    Marshall JC
    Shock; 2005 Dec; 24 Suppl 1():120-9. PubMed ID: 16374383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus.
    De Groote MA; Johnson L; Podell B; Brooks E; Basaraba R; Gonzalez-Juarrero M
    J Antimicrob Chemother; 2014 Apr; 69(4):1057-64. PubMed ID: 24222613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating factor enhances host defenses against bacterial pneumonia following peritonitis in nonneutropenic rats.
    Attalah HL; Azoulay E; Yang K; Lasclos C; Jouault H; Soussy CJ; Guillot T; Brochard L; Brun-Buisson C; Harf A; Delclaux C
    Crit Care Med; 2002 Sep; 30(9):2107-14. PubMed ID: 12352049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients?
    Azoulay E; Delclaux C
    Intensive Care Med; 2004 Jan; 30(1):10-7. PubMed ID: 14593456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases.
    Daifuku R; Andresen J; Morstyn G
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():91-7. PubMed ID: 7691789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
    Babalola CP; Nightingale CH; Nicolau DP
    J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
    Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor.
    O'Reilly M; Silver GM; Greenhalgh DG; Gamelli RL; Davis JH; Hebert JC
    J Trauma; 1992 Nov; 33(5):679-82. PubMed ID: 1281510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of innate immunity with granulocyte colony-stimulating factor did not mitigate disease in pigs infected with a highly pathogenic Chinese PRRSV strain.
    Schlink SN; Lager KM; Brockmeier SL; Loving CL; Miller LC; Vorwald AC; Yang HC; Kehrli ME; Faaberg KS
    Vet Immunol Immunopathol; 2016 Oct; 179():70-6. PubMed ID: 27590428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil apoptosis, activation and anti-inflammatory cytokine response in granulocyte colony-stimulating factor-treated patients with community-acquired pneumonia.
    Droemann D; Hansen F; Aries SP; Braun J; Zabel P; Dalhoff K; Schaaf B
    Respiration; 2006; 73(3):340-6. PubMed ID: 16369129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor has differing effects comparing intravascular versus extravascular models of sepsis.
    Sevransky JE; Parent C; Cui X; Karzai W; Fitz Y; Banks SM; Gerstenberger E; Danner RL; Natanson C; Eichacker PQ
    J Trauma; 2004 Sep; 57(3):618-25. PubMed ID: 15454812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor (G-CSF) reduces not only gram-negative but also gram-positive infection-associated proinflammatory cytokine release by interaction between Kupffer cells and leukocytes.
    Busch CJ; Wanner GA; Menger MD; Vollmar B
    Inflamm Res; 2004 May; 53(5):205-10. PubMed ID: 15105970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of granulocyte colony-stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage.
    Abraham E; Stevens P
    Crit Care Med; 1992 Aug; 20(8):1127-33. PubMed ID: 1379529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
    Cirioni O; Ghiselli R; Kamysz W; Orlando F; Silvestri C; Mocchegiani F; Di Matteo F; Kamysz E; Riva A; Rocchi M; Saba V; Scalise G; Giacometti A
    Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: granulocyte colony-stimulating factor--role and relationships in infectious diseases.
    Dale DC; Liles WC; Summer WR; Nelson S
    J Infect Dis; 1995 Oct; 172(4):1061-75. PubMed ID: 7561181
    [No Abstract]   [Full Text] [Related]  

  • 19. Granulocyte colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults.
    Cheng AC; Stephens DP; Currie BJ
    Cochrane Database Syst Rev; 2003; (4):CD004400. PubMed ID: 14584011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escherichia coli pneumonia enhances granulopoiesis and the mobilization of myeloid progenitor cells into the systemic circulation.
    Shahbazian LM; Quinton LJ; Bagby GJ; Nelson S; Wang G; Zhang P
    Crit Care Med; 2004 Aug; 32(8):1740-6. PubMed ID: 15286552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.